TSBX - Turnstone Biologics Corporation P/S Multiple

Brandmark of turnstonebio.com (TSBX)

The modern immuno-oncology market is actively developing distribution networks amid high demand for solid tumor treatments. Turnstone Biologics (TSBX) aims to establish TIL therapy as the benchmark for a personalized approach. Monitoring the company's P/S ratio shows that 3.60 is becoming the new value for this metric, while the long-term patents of the Inertia platform ensure stable margins and commercial sustainability in partnerships with pharma behemoths.

TSBX (Turnstone Biologics) Price-to-Revenue Ratio history from 03/23/2024 to 05/14/2024

Turnstone Biologics (TSBX) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Quotes turnstonebio.com|TSBX - Consensus Target
- market capitalization statistics:
Market Capitalization Turnstone Biologics Corporation|TSBX - Total Company Value
- balance sheet equity data:
Equity per Share Turnstone Biologics|TSBX - Company Book Value|Market-to-Book Ratio turnstonebio.com|TSBX - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Debt to Capital Ratio Turnstone Biologics|TSBX - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio turnstonebio.com|TSBX - Company Aggregate Debts|Debt to Net Assets Ratio Turnstone Biologics Corporation|TSBX - Company Long-Term Debts|Short-Term Debt Turnstone Biologics|Intermediate Coverage Ratio turnstonebio.com
- net income and valuation multiples indicators:
TSBX - Net Profit|Projected Future Earnings Turnstone Biologics|TSBX - Price to Earnings Ratio|Price to Expected Earnings Ratio turnstonebio.com|TSBX - Price/Earnings to Growth Multiple|Company Value to EBITDA Turnstone Biologics Corporation|TSBX - Operating profit before deduction of amortization|Earnings per share for the last four quarters Turnstone Biologics|TSBX - Net earnings per share for the last 12 months|Quarterly EPS earnings growth turnstonebio.com|TSBX - Earnings per share growth in current year|Expected earnings per share trend next year Turnstone Biologics
- total revenue and sales volume data:
TSBX - Company Revenue|Company Revenue Forecast turnstonebio.com|TSBX - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Turnstone Biologics Corporation
General company analysis:Turnstone Biologics Corp, TSBX
Manufactured product of Turnstone Biologics Corporation

The P/S ratio is calculated as the ratio of Turnstone Biologics (TSBX) market capitalization to its annual revenue, measuring the value of each unit of sales in the eyes of investors. Amidst the fierce battle for patents in the TIL therapy sector, the price/sales trend reflects the market's confidence in the commercial success of the company's drugs despite pressure from biotech behemoths.

Competing companies

Market Cap to Revenue immunitybio.com IBRX|Immunocore - Market Cap to Revenue|P/S Multiple Janux Therapeutics Inc JANX|RCUS - Price-to-Revenue Ratio|ZYME (Zymeworks Biopharmaceuticals) - Market Cap to Revenue Ratio|Tango Therapeutics (TNGX) - Price-to-Revenue Ratio|Price to Sales iovance.com (IOVA)|Market Cap to Revenue IMTX|XNCR - Price-to-Revenue Multiple|Market Cap to Revenue CMPX (Compass Bio)|Market Cap to Sales Volume REPL|P/S Multiple LYEL (Lyell Immunopharma)|Market Capitalization-to-Revenue Ratio IPHA|Pyxis - P/S Multiple|Price to Sales Compugen Ltd.|IO Biotech Corp (IOBT) - Price-to-Revenue Ratio|Sutro Biopharma, Inc - Market Capitalization-to-Revenue Ratio|INKT (MiNK Therapeutics, Inc.) - P/S Multiple|P/S Multiple Werewolf|Price-to-Revenue Ratio Immix Biopharma, Inc. (IMMX)|ALXO: Price-to-Sales Ratio|Cue Biopharma, Inc. - Market Cap to Revenue|PDS Biotech (PDSB) - Price to Sales|SONN: Market Cap to Revenue|MAIABiotech.com - Market Cap to Sales Volume|LIMN (Liminatus Pharma LLC) - Market Cap to Revenue|LAVA Therapeutics (LVTX) - P/S Multiple|Price-to-Revenue Ratio NextCure Corp|LPTX: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Intensity Therapeutics (INTS)|senseibio.com - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Theriva Biologics TOVX|Price-to-Revenue Coefficient Gritstone bio Inc. (GRTS)|KA: Market Cap to Revenue|NexImmune Corporation - Market Cap to Sales Volume|Vaccinex, Inc. (VCNX) - Price-to-Revenue Ratio|Price to Sales harpoontx.com (HARP)